Author

Mayur D. Mody

Kennedy Krieger InstituteORCID 0000-0002-0594-6677Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Elizabeth Anne Kolar· 1 shared Emily M. Clay· 1 shared John E. Locke· 1 shared Paul A. WatkinsiD· 1 shared Xiaohai ShiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Elizabeth Anne Kolar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintJul 2, 2025

Toward pharmacologic therapy for glioblastoma: Identifying inhibitors of very long-chain acyl-CoA synthetase 3 (ACSVL3)

Emily M. Clay, Xiaohai Shi, Elizabeth Anne Kolar…·Paul A. Watkins

This paper identifies potential inhibitors of ACSVL3, an enzyme overexpressed in glioblastoma, using in vitro assays and a high-throughput screening approach.

DOI 10.1101/2025.07.02.662811

humanbulk RNA-seq

𝕏 PostBluesky